Trump Announces 100 Per Cent Tariff On Imported Pharmaceuticals Without US-Based Manufacturing Plants

The announcement by U.S. President Donald Trump of a sweeping set of new tariffs marks a sharp escalation in his administration’s trade policy, particularly targeting pharmaceuticals and consumer goods. Beginning October 1, 2025, the United States will impose a 100 percent tariff on all branded and patented pharmaceutical products that are not accompanied by U.S.-based manufacturing
The announcement by U.S. President Donald Trump of a sweeping set of new tariffs marks a sharp escalation in his administration’s trade policy, particularly targeting pharmaceuticals and consumer goods. Beginning October 1, 2025, the United States will impose a 100 percent tariff on all branded and patented pharmaceutical products that are not accompanied by U.S.-based manufacturing
Go to Source